Quantitative phosphoproteomics reveals ectopic ATP synthase on mesenchymal stem cells to promote tumor progression via ERK/c-Fos pathway activation

The tumor microenvironment (TME), which comprises cellular and noncellular components, is involved in the complex process of cancer development. Emerging evidence suggests that mesenchymal stem cells (MSCs), one of the vital regulators of the TME, foster tumor progression through paracrine secretion. However, the comprehensive phosphosignaling pathways that are mediated by MSC-secreting factors have not yet been fully established. In this study, we attempt to dissect the MSC-triggered mechanism in lung cancer using quantitative phosphoproteomics. A total of 1958 phosphorylation sites are identified in lung cancer cells stimulated with MSC conditioned medium. Integrative analysis of the identified phosphoproteins and predicted kinases demonstrates that MSC-conditioned medium functionally promotes the proliferation and migration of lung cancer via the ERK/ phospho-c-Fos-S374 pathway. Recent studies have reported that extracellular ATP accumulates in the TME and stimulates the P2X7R on the cancer cell membrane via purinergic signaling. We observe that ectopic ATP synthase is located on the surface of MSCs and excreted extracellular ATP into the lung cancer microenvironment to trigger the ERK/phospho-c-Fos-S374 pathway, which is consistent with these previous findings. Our results suggest that ectopic ATP synthase on the surface of MSCs releases extracellular ATP into the TME, which promotes cancer progression via activation of the ERK/phospho-cFos-S374 pathway.

Automated summary

The tumor microenvironment plays a crucial role in cancer development. This study reveals that mesenchymal stem cells (MSCs), a key regulator of the microenvironment, promote lung cancer progression through the ERK/phospho-c-Fos-S374 pathway, as demonstrated by quantitative phosphoproteomics analysis. Additionally, the study also highlights the role of extracellular ATP, secreted by ATP synthase on the surface of MSCs, in activating the ERK/phospho-c-Fos-S374 pathway in lung cancer cells. These findings contribute to a better understanding of the complex interactions within the tumor microenvironment and provide potential targets for therapeutic interventions.